Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patent Office on Patent Reform

Once again how can people keep making this statements. In the last shareholder letter Mr. Turley specifically stated:

"In July, 2007, we advised you of pending federal legislation regarding the 2007 Patent Reform bill, which we believe if passed would negatively impact the future success of our licensing program. TPL has devoted an enormous amount of time to this issue and has prepared very valuable information, which is posted on their website."

This statement should be taken at face value, otherwise, I want to know what kind of public company proceeds to make statements about how pending legislation will negatively impact future earnings if it isn't true. PTSC can't be speaking to the future because that would be pure speculation based on things they aren't currently engaged in. As I said the other day if your assumption is correct, than Mr. Turley is obligated to inform investors.

Share
New Message
Please login to post a reply